Inflammatory Disorders: Articles published @ pharmaceuticalintelligence.com
Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
This is a compilation of articles on Inflammatory Disorders that were published
@ pharmaceuticalintelligence.com, since 4/2012 to date
There are published works that have not been included. However, there is a substantial amount of material in the following categories:
- The systemic inflammatory response
http://pharmaceuticalintelligence.com/2014/11/08/introduction-to-impairments-in-pathological-states-endocrine-disorders-stress-hypermetabolism-cancer/Neutrophil Serine Proteases in Disease and Therapeutic Considerations
What is the key method to harness Inflammation to close the doors for many complex diseases?
Therapeutic Targets for Diabetes and Related Metabolic Disorders
A Second Look at the Transthyretin Nutrition Inflammatory Conundrum
Zebrafish Provide Insights Into Causes and Treatment of Human Diseases
http://pharmaceuticalintelligence.com/2013/03/06/can-resolvins-suppress-acute-lung-injury/
http://pharmaceuticalintelligence.com/2015/02/26/acute-lung-injury/ - sepsis
http://pharmaceuticalintelligence.com/2012/10/20/nitric-oxide-and-sepsis-hemodynamic-collapse-and-the-search-for-therapeutic-options/ - vasculitis
http://pharmaceuticalintelligence.com/2015/02/26/acute-lung-injury/The Molecular Biology of Renal Disorders: Nitric Oxide – Part III
http://pharmaceuticalintelligence.com/2012/11/20/the-potential-for-nitric-oxide-donors-in-renal-function-disorders/
- neurodegenerative disease
http://pharmaceuticalintelligence.com/2013/02/27/ustekinumab-new-drug-therapy-for-cognitive-decline-resulting-from-neuroinflammatory-cytokine-signaling-and-alzheimers-disease/ - cancer immunology
http://pharmaceuticalintelligence.com/2013/04/12/innovations-in-tumor-immunology/Gene Expression and Adaptive Immune Resistance Mechanisms in Lymphoma
The Delicate Connection: IDO (Indolamine 2, 3 dehydrogenase) and Cancer Immunology
- autoimmune diseases: rheumatoid arthritis, colitis, ileitis, …
http://pharmaceuticalintelligence.com/2016/02/11/intestinal-inflammatory-pharmaceutics/
http://pharmaceuticalintelligence.com/2016/01/07/two-new-drugs-for-inflammatory-bowel-syndrome-are-giving-patients-hope/
http://pharmaceuticalintelligence.com/2015/12/16/contribution-to-inflammatory-bowel-disease-ibd-of-bacterial-overgrowth-in-gut-on-a-chip/
http://pharmaceuticalintelligence.com/2013/08/04/the-delicate-connection-ido-indolamine-2-3-dehydrogenase-and-immunology/
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Approach to Controlling Pathogenic Inflammation in Arthritis
- T cells in immunity
http://pharmaceuticalintelligence.com/2015/09/07/t-cell-mediated-immune-responses-signaling-pathways-activated-by-tlrs/Immunity and Host Defense – A Bibliography of Research @Technion
The Delicate Connection: IDO (Indolamine 2, 3 dehydrogenase) and Cancer Immunology
http://pharmaceuticalintelligence.com/2013/04/14/immune-regulation-news/
Proteomics, metabolomics and diabetes
http://pharmaceuticalintelligence.com/2015/11/16/reducing-obesity-related-inflammation/
http://pharmaceuticalintelligence.com/2015/03/07/transthyretin-and-the-stressful-condition/
http://pharmaceuticalintelligence.com/2015/02/13/neural-activity-regulating-endocrine-response/
http://pharmaceuticalintelligence.com/2015/01/31/proteomics/
http://pharmaceuticalintelligence.com/2014/11/01/summary-of-signaling-and-signaling-pathways/
http://pharmaceuticalintelligence.com/2014/10/24/diabetes-mellitus/
http://pharmaceuticalintelligence.com/2014/10/16/metabolomics-summary-and-perspective/
http://pharmaceuticalintelligence.com/2014/10/14/metabolic-reactions-need-just-enough/
http://pharmaceuticalintelligence.com/2014/11/03/introduction-to-protein-synthesis-and-degradation/
http://pharmaceuticalintelligence.com/2015/09/25/proceedings-of-the-nyas/
http://pharmaceuticalintelligence.com/2012/11/26/new-insights-on-no-donors/
Leave a Reply